Ameriprise’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-539
Closed -$3.73K 3993
2025
Q1
$3.73K Buy
539
+22
+4% +$238 ﹤0.01% 4008
2024
Q4
$6.21K Sell
517
-9
-2% -$208 ﹤0.01% 4067
2024
Q3
$16.7K Buy
526
+9
+2% +$317 ﹤0.01% 3914
2024
Q2
$18K Hold
517
﹤0.01% 3842
2024
Q1
$29.6K Hold
517
﹤0.01% 3823
2023
Q4
$42.2K Hold
517
﹤0.01% 3857
2023
Q3
$19.4K Hold
517
﹤0.01% 3866
2023
Q2
$37.4K Sell
517
-21
-4% -$1.53K ﹤0.01% 3876
2023
Q1
$37.5K Buy
538
+4
+0.7% +$313 ﹤0.01% 3884
2022
Q4
$38K Sell
534
-46
-8% -$4.05K ﹤0.01% 3873
2022
Q3
$54K Sell
580
-27
-4% -$3.25K ﹤0.01% 3890
2022
Q2
$82K Sell
607
-80
-12% -$8.33K ﹤0.01% 3804
2022
Q1
$81K Buy
687
+164
+31% +$26.7K ﹤0.01% 3864
2021
Q4
$111K Sell
523
-73
-12% -$22.4K ﹤0.01% 3865
2021
Q3
$197K Buy
596
+24
+4% +$7K ﹤0.01% 3706
2021
Q2
$149K Buy
572
+39
+7% +$24.1K ﹤0.01% 3787
2021
Q1
$243K Sell
533
-409
-43% -$223K ﹤0.01% 3660
2020
Q4
$329K Sell
942
-193
-17% -$76.1K ﹤0.01% 3474
2020
Q3
$434K Buy
1,135
+49
+5% +$19.3K ﹤0.01% 3288
2020
Q2
$486K Buy
1,086
+101
+10% +$41.5K ﹤0.01% 3207
2020
Q1
$341K Buy
985
+604
+159% +$221K ﹤0.01% 3264
2019
Q4
$104K Hold
381
﹤0.01% 3641
2019
Q3
$102K Hold
381
﹤0.01% 3632
2019
Q2
$96K Hold
381
﹤0.01% 3663
2019
Q1
$40K Sell
381
-33
-8% -$2.83K ﹤0.01% 3658
2018
Q4
$36K Hold
414
﹤0.01% 3581
2018
Q3
$50K Buy
+414
New +$23.8K ﹤0.01% 3663
2017
Q2
Sell
-33
Closed -$2K 3739
2017
Q1
$2K Hold
33
﹤0.01% 3603
2016
Q4
$2K Hold
33
﹤0.01% 3859
2016
Q3
$8K Hold
33
﹤0.01% 3761
2016
Q2
$11K Sell
33
-6
-15% -$2.36K ﹤0.01% 3736
2016
Q1
$16K Buy
39
+1
+3% +$382 ﹤0.01% 3715
2015
Q4
$11K Buy
+38
New +$14.8K ﹤0.01% 3849
2014
Q4
Sell
-4
Closed -$3K 3827
2014
Q3
$3K Hold
4
﹤0.01% 5288
2014
Q2
$4K Buy
+4
New +$3.65K ﹤0.01% 5004

Other funds holding CVM

Ameriprise's CVM Position: Q2 2025 in Review

Ameriprise sold out of CEL-SCI Corp (CVM) in Q2 2025, closing a stake of 539 shares — an estimated $3.73K sold.

Ameriprise first reported a position in CVM in Q2 2014 and held it in 35 quarters. The position peaked at $486K in Q2 2020. 28 funds tracked by Wall St. Rank hold CVM as of Q2 2025.

  • Ameriprise reported no remaining CEL-SCI Corp position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 539 CEL-SCI Corp shares in Q2 2025, an estimated $3.73K.
  • Ameriprise first reported a position in CEL-SCI Corp in Q2 2014 and held it in 35 quarters.
  • Ameriprise's CEL-SCI Corp position peaked at $486K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.